NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases
Authors:
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Practical Radiation Oncology
- Vol. 9 (4) , e386-e393
Abstract
No abstract availableKeywords
Funding Information
- NRG Oncology Statistics and Data Management Center (U10CA180822)
- NRG Oncology Operations (U10CA180868)
- National Cancer Institute (CA81647)
This publication has 30 references indexed in Scilit:
- Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapyPractical Radiation Oncology, 2014
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Stereotactic body radiotherapy for colorectal liver metastasesCancer, 2011
- Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor RadiosurgeryPLOS ONE, 2010
- Stereotactic body radiation therapy for colorectal liver metastasesBritish Journal of Surgery, 2010
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyJournal of Clinical Oncology, 2009
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatmentBlood, 2009
- Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver MetastasesJournal of Clinical Oncology, 2009
- Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery Floxuridine for Unresectable Intrahepatic MalignanciesJournal of Clinical Oncology, 2005
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000